# FDA Inspection 1260981 - LifeCenter Northwest - February 10, 2025

Source: https://www.keypedia.com/records/fda_inspections/lifecenter-northwest/01eea543-c501-4d11-af3c-2783e426adb3
Source feed: FDA_Inspections

> FDA Inspection 1260981 for LifeCenter Northwest on February 10, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1260981
- Company Name: LifeCenter Northwest
- Inspection Date: 2025-02-10
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1260981 - 2025-02-10](https://www.keypedia.com/records/fda_inspections/lifecenter-northwest/965fdc0d-6b28-4461-951f-9dad4f537413)
- [FDA Inspection 1071116 - 2018-10-22](https://www.keypedia.com/records/fda_inspections/lifecenter-northwest/faed31d0-ef18-4dcd-b226-1443fd0e27fc)

Company: https://www.keypedia.com/companies/lifecenter-northwest/2a32021e-016f-4196-8536-c70331ca2d05

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d